The nation's leading group of cancer specialists said Sunday that it was premature for post Menopausal women with early breast cancer to switch to a newer class of drugs from Tamoxifen, the drug that has long been the standard in preventing recurrence.
Doctors advise against switching drugs for breast cancer.